Orciprenaline
Top View
- Supplementary Material A: RECORD Statement
- Stembook 2018.Pdf
- Drug/Substance Trade Name(S)
- United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
- Supplementary File
- PRODUCT MONOGRAPH Pr SANDOZ SALBUTAMOL (Salbutamol Sulfate Inhalation Solution) 0.5% 5 Mg/Ml Bronchodilator Beta2-Adrenergic
- Council of Europe Committee of Ministers (Partial
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Asthma and Exercise-Induced Respiratory Disorders in Athletes. the Position Paper of the Polish Society of Allergology and Polish Society of Sports Medicine
- Striving for Optimal Bronchodilation: Focus on Olodaterol
- Examples of Prohibited and Permitted Substances And
- 2019 Equine Prohibited Substances List
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Indian Science Congress, Part II : Presidential Address
- Palu Ent ~~Orciprenaline
- WO 2016/161086 Al 6 October 2016 (06.10.2016) P O P C T
- Customs Tariff - Schedule Xxi - 1
- Drug Index and Glossary